[HTML][HTML] Qiliqiangxin prevents right ventricular remodeling by inhibiting apoptosis and improving metabolism reprogramming with pulmonary arterial hypertension

Y Lu, J Wu, Y Sun, L Xin, Z Jiang, H Lin… - American Journal of …, 2020 - ncbi.nlm.nih.gov
Pathological remodeling of the right ventricular (RV) contributes to the mortality of pulmonary
arterial hypertension (PAH) patients, and RV myocardial apoptosis and metabolism play …

[HTML][HTML] Qiliqiangxin attenuates adverse cardiac remodeling after myocardial infarction in ovariectomized mice via activation of PPARγ

S Shen, H Jiang, Y Bei, J Zhang, H Zhang… - Cellular Physiology and …, 2017 - karger.com
Background/Aims: This study was designed to investigate the therapeutic effect of traditional
Chinese medication Qiliqiangxin (QLQX) on adverse cardiac remodeling after myocardial …

Pyrroloquinoline quinone modulates YAP-related anti-ferroptotic activity to protect against myocardial hypertrophy

J Zhou, T Yu, G Wu, P Xu, C Wang, Y Su… - Frontiers in …, 2022 - frontiersin.org
Background: Pyrroloquinoline quinone (PQQ) has been reported to exhibit cardioprotective
and antioxidant activities. Accordingly, this study was developed to explore the effects of …

[PDF][PDF] Qiliqiangxin capsule improves cardiac remodeling in rats with DOCA-salt-induced diastolic dysfunction.

JM Hao, P Sun, Y Zeng, H Zhang… - European Review for …, 2023 - europeanreview.org
OBJECTIVE: The aim of this study was to investigate the protective effect and mechanism of
action (MOA) of Qiliqiangxin capsule (QL) in the deoxycorticosterone acetate (DOCA) salt …

[HTML][HTML] Cardio-protecteffect of qiliqiangxin capsule on left ventricular remodeling, dysfunction and apoptosis in heart failure rats after chronic myocardial infarction

T Liang, Y Zhang, S Yin, T Gan, T An… - American journal of …, 2016 - ncbi.nlm.nih.gov
Background: Qiliqiangxin (QL) capsule is a traditional Chinese medicine which has been
approved for the treatment of chronic heart failure. Evidences proved that QL capsules …

Analysis of microRNA expression profiles induced by Yiqifumai injection in rats with chronic heart failure

Y Zhao, Y Li, L Tong, X Liang, H Zhang, L Li… - Frontiers in …, 2018 - frontiersin.org
Background: Yiqifumai Injection (YQFM) is clinically used to treat various cardiovascular
diseases including chronic heart failure (CHF). The efficacy of YQFM for treating heart failure …

[HTML][HTML] Tetramethylpyrazine inhibits angiotensin II-induced cardiomyocyte hypertrophy and tumor necrosis factor-α secretion through an NF-κB-dependent …

L Yu, T She, M Li, C Shi, L Han… - … Journal of Molecular …, 2013 - spandidos-publications.com
Tetramethylpyrazine (TMP), a bioactive compound isolated from the Chinese herb,
Ligusticum wallichii Franchat, has been reported to play a protective role in cardiac …

Qiliqiangxin prescription promotes angiogenesis of hypoxic primary rat cardiac microvascular endothelial cells via regulating miR-21 signaling

Y Wang, J Zhang, M Fu, J Wang, X Cui… - Current …, 2021 - ingentaconnect.com
Background and Objective: Angiogenesis is the most important repair process of tissues
subjected to ischemic injury. The present study aims to investigate whether the pro …

Chronic treatment with qiliqiangxin ameliorates aortic endothelial cell dysfunction in diabetic rats

F Chen, JL Wu, GS Fu, Y Mou… - Journal of Cardiovascular …, 2015 - journals.sagepub.com
Qiliqiangxin (QL), a traditional Chinese medicine, has been shown to be beneficial for
chronic heart failure. However, whether QL can also improve endothelial cell function in …

Beneficial Effects of Qili Qiangxin Capsule on Lung Structural Remodeling in Ischemic Heart Failure via TGF‐β1/Smad3 Pathway

Y He, B Du, H Fan, J Cao, ZW Liu… - Evidence‐Based …, 2015 - Wiley Online Library
Qili qiangxin (QL) capsule is a traditional Chinese medicine that is widely used for the
treatment of patients with chronic heart failure (CHF) of all etiologies, although the exact …